Milad Ibrahim

7PUBLICATIONS
38CO-AUTHORS
Cancer geneticsMolecular targetsPredictive and prognostic markersImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 25, 2026
Genotype-driven tumor ecosystems drive immune evasion and immunotherapy resistance in melanoma.

|Jun 03, 2026
Loss of AMBRA1 activates MAPK and angiogenesis signaling pathways in melanoma cells.

|Feb 06, 2026
NF1 Loss Remodels Tumor Niches for Immune Evasion.

Milad Ibrahim, Irineu Illa-Bochaca, Tara Muijlwijk

|Jun 24, 2025
Artificial Intelligence Algorithm Predicts Response to Immune Checkpoint Inhibitors.

Faisal Fa'ak, Nicolas Coudray, George Jour

|Jun 10, 2025
NF1 Loss Promotes EGFR Activation and Confers Sensitivity to EGFR Inhibition in NF1-Mutant Melanoma.

Milad Ibrahim, Irineu Illa-Bochaca, George Jour

|Jun 05, 2025
Inherited mitochondrial genetics as a predictor of immune checkpoint inhibition efficacy in melanoma.

Kelsey R Monson, Robert Ferguson, Joanna E Handzlik

Pageof 2

Frequent Collaborators

3 joint publications

Iman Osman

3 joint publications

George Jour

3 joint publications

Irineu Illa-Bochaca

2 joint publications

Faisal Fa'ak